| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 11 | +63.64% | -5.10% | -0.29% | -4.81% | -2.92% | — |
| 14d | 11 | +36.36% | +4.14% | +1.32% | +2.83% | +5.08% | — |
| 30d | 11 | +45.45% | -0.50% | +1.49% | -1.99% | +0.70% | — |
| 60d | 11 | +72.73% | -10.97% | +2.02% | -12.99% | -3.26% | — |
| 90d | 11 | +63.64% | -16.71% | -0.08% | -16.62% | -23.44% | — |
| 180d | 11 | +90.91% | -40.96% | +0.02% | -40.98% | -38.29% | — |
| 1y | 11(1 pending) | +100.00% | -51.92% | +16.17% | -68.10% | -66.32% | — |
| 2y | 11(11 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 96,600 | — | — | 381,582 | Jan 2, 2026 | Jan 2, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 338,100 | — | — | 338,100 | Jan 2, 2026 | Jan 2, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE President and CEO | 8,072 | $13.73 | $110.8K | 284,982 | Jan 2, 2026 | Jan 2, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $60.00 | $300.0K | 293,054 | Jan 7, 2025 | Jan 8, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 283,500 | — | — | 283,500 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 81,000 | — | — | 298,054 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 25,000 | $56.19 | $1.40M | 217,054 | Dec 24, 2024 | Dec 27, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 15,000 | $67.00 | $1.00M | 242,054 | Dec 3, 2024 | Dec 3, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 18,281 | $51.43 | $940.2K | 263,773 | Nov 25, 2024 | Nov 27, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 6,719 | $52.04 | $349.6K | 257,054 | Nov 25, 2024 | Nov 27, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 11,103 | $53.94 | $598.9K | 282,054 | Oct 28, 2024 | Oct 30, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 13,897 | $53.22 | $739.6K | 293,157 | Oct 28, 2024 | Oct 30, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 18,957 | $46.09 | $873.7K | 313,097 | Sep 27, 2024 | Sep 27, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,248 | $46.86 | $245.9K | 307,849 | Sep 27, 2024 | Sep 27, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 795 | $47.84 | $38.0K | 307,054 | Sep 27, 2024 | Sep 27, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 356,500 | — | — | 356,500 | Jan 2, 2024 | Jan 3, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 310,000 | — | — | 310,000 | Jan 3, 2023 | Jan 5, 2023 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 354,250 | — | — | 354,250 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |